Adamas Pharma

ADMS NASDAQ
6.42
+0.14
+2.23%
盘后: 6.42 0 0.00% 17:00 08/16 EDT
开盘
6.34
昨收
6.28
最高
6.72
最低
6.25
成交量
30.29万
成交均量(3M)
36.71万
52周最高
23.36
52周最低
4.200
换手率
1.09%
市值
1.78亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Adamas Pharma ADMS股票价格,Adamas Pharma股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Adamas Pharmaceuticals, Inc. is a pharmaceutical company. The Company is engaged in developing medicines to manage the daily lives of those affected by chronic neurologic disorders. It offers a platform based on an understanding of time dependent biologic effects of disease activity and drug response to achieve relief without tolerability issues. It has developed a portfolio of chrono-synchronous therapies to address chronic neurologic disorders. Its first product candidate is ADS-5102, a chrono-synchronous amantadine therapy, for the treatment of levodopa-induced dyskinesia (LID) in patients with Parkinson's disease (PD). It has completed Phase II proof-of-concept study of ADS-5102 in these patients. Its Phase III clinical program included three placebo-controlled trials: EASED, EASE LID and EASE LID 3. Its second product candidate is ADS-4101, an extended-release version of single-agent compound for the treatment of epilepsy (partial onset seizures).
展开 >

最近浏览

名称
价格
涨跌幅